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Abstract
Introduction: Breast cancer is the most common form of cancer among women, with an estimated 194,280 new
cases diagnosed in the United States in 2009 alone. The primary aim of this work was to provide an in-depth
evaluation of research yield in breast cancer from 1945 to 2008, using large-scale data analysis, the employment of
bibliometric indicators of production and quality, and density-equalizing mapping.
Methods: Data were retrieved from the Web of Science (WOS) Science Citation Expanded database; this was
searched using the Boolean operator, ‘OR’, with different terms related to breast cancer, including “breast cancer”,
“mammary ductal carcinoma” and “breast tumour”. Data were then extracted from each file, transferred to Excel
charts and visualised as diagrams. Mapping was performed as described by Groneberg-Kloft et al. in 2008.
Results: A total of 180,126 breast cancer-associated items were produced over the study period; these had been
cited 4,136,224 times. The United States returned the greatest level of output (n = 77,101), followed by the UK (n =
18,357) and Germany (n = 12,529). International cooperation peaked in 2008, with 3,127 entries produced as a result;
relationships between the United States and other countries formed the basis for the 10 most common forms of
bilateral cooperation. Publications from nations with high levels of international cooperation were associated with
greater average citation rates. A total of 4,096 journals published at least one item on breast cancer, although the top
50 most prolific titles together accounted for over 43% (77,517/180,126) of the total output.
Conclusions: Breast cancer-associated research output continues to increase annually. In an era when bibliometric
indicators are increasingly being employed in performance assessment, these findings should provide useful
information for those tasked with improving that performance.
Introduction
In 2009, an estimated 194,280 new cases of breast can-
cer were diagnosed in the United States; breast cancer
was estimated to account for 27% of all new cancer
cases and 15% of cancer-related mortality in women [1].
Similarly, in Europe in 2008, the disease was reckoned
to account for some 28% and 17% of new cancer cases
and cancer-related mortality in women, respectively [2].
The last 50 years have seen an exponential increase in
scientific yield generally, and particularly in oncology; a
recent report demonstrated that in January of 2009 alone
there were 11,215 new cancer-related papers and 1,220
review articles indexed in Pubmed [3]. The importance
of quantitative and qualitative assessment of scientific
output has increased in tandem with this information
explosion, and these assessments now play an integral
role in decisions regarding grant funding and prioritisa-
tion of resources, as exemplified by the Research Assess-
ment Exercise in the UK [4]. Despite its aforementioned
disease burden, relatively little effort has previously been
made to understand the trends emanating from the
breast cancer-associated literature. While there has been
some concentration on the bibliometrics of cancer
research generally [5,6], just three publications have eval-
uated breast-related output specifically; Dalpe et al.
focused on the identification of BRCA1 and BRCA2 in
the 1990 s [7], while Donato et al. published an analysis
of the Portuguese contribution [8], and Li and McCain
focused specifically on the development of research
themes in the radiological detection of breast cancer [9].
The primary aim of this present work was thus to provide
an in-depth evaluation of research yield in breast cancer
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employment of bibliometric indicators of production and
quality, and density-equalizing mapping.
Materials and methods
Data source
Data were retrieved from the Web of Science (WOS)
Science Citation Expanded database (SCI-Expanded) pro-
duced by Thomson Reuters. In order to approximate the
overall number of published items on breast cancer, the
following search strategy was employed; TS = ((phyllodes
tumo$r$) OR (Cystosarcoma Phyllo$des) OR (Malignant
Cystosarcoma Phyllodes) OR (breast invasive ductal car-
cinoma) OR (infiltrating duct carcinoma$) OR (mam-
mary ductal carcinoma$) OR (breast cancer) OR (breast
neoplasm$) OR (breast tumo$r$) OR (human mammary
neoplasm$) OR (human mammary carcinoma$)) where
TS = Topic search, $ = any character. Because this work
was designed to assess overall activity in relation to
breast cancer, we did not refine our search to include
some document types such as original articles or reviews,
or to exclude others such as letters and editorials. The
time span analysed was 1945 to 2008 inclusive. The
search was performed in November 2009, and thus 2009
was excluded as database entries for this period would
not have been complete at the time of the search.
Each item of information downloaded from the WOS
was contained in a ‘data block’. Each block was preceded
by a tag which gave information about the content of
the block (that is, AU = authors, TI = title, PY = publi-
cation year). Software developed at the Charite Univer-
sity in Berlin was then employed to parse the data. Each
time it found a tag it read the associated data and saved
it to an Access database; the information was then later
transferred to an Excel database for analysis. Published
items were analysed using the citation report method as
described previously [10,11]. The number of citations
per year and the average number of citations per item
were assessed, thereby indicating the average number of
citing articles for all items in the set. This is the sum of
the times cited divided by the number of results found.
Mapping was performed as described by Groneberg-
Kloft et al. in 2008 [12]. Those nations which had contrib-
uted output were resized according to one of a number of
different variables under study; that is, the average number
of citations per item from each country. As part of this
resizing procedure, the area of each country was scaled
relative to, for example, the total number of items it had
p u b l i s h e do nb r e a s tc a n c e r .Specific calculations were
based on Gastner and Newman’s algorithm [13], published
in 2004. These calculations employ a diffusion equation in
the Fourier domain borrowed from elementary physics,
which allows variable resolution by tracking moving
boundaries [13,14].
Cooperation analysis was employed to determine bilat-
eral and multilateral cooperation between countries on
breast cancer research. A cooperation network between
countries was computed by checking all combinations of
those countries which registered international cooperation
on at least 25 items over the study period. These data
were then saved to a “matrix” or two-dimensional table,
and the software then read this matrix and produced a
density-equalising map which graphically represented this
data. The threshold of 25 articles was set to improve
readability.
Journals which had published on breast cancer were
analysed relative to both the Journal Impact Factor (IF)
and the recently developed Eigenfactor (EF). The former is
based on two elements; the numerator, which is the num-
ber of citations in the current year to items published in
the previous two years, and the denominator, which is the
number of substantive articles and reviews published in
the same two years [15]. The EF is calculated based on a
complex algorithm that takes into account not only the
quantity of citations but also their “quality” by assigning
weights to the source of the citations. The full details of
the algorithm can be found online [16].
Results
Total number of published items
The number of published items on breast cancer was
employed as an index of research productivity. During
the period 1945 to 2008 (1974 excluded, n = 352), a
total of 180,126 items were produced on this topic, as
catalogued in the WOS. The earliest studies catalogued
were published in 1945 (n = 17), although it was 1990
before activity began to increase considerably, year on
year (Figure 1); output more than doubled from 1990 (n
= 1,436) to 1992 (n = 3,342). The greatest output for
any year was that for 2008 (n = 17,413).
Total number of citations
The 180,126 indexed items have been cited 4,136,224
times since 1945. Figure 1 demonstrates the parallel
increase in the number of citations in conjunction with
t h ei n c r e a s ei np u b l i s h e di t e ms. Articles published in
2001 were responsible for more citations than those
published in any other year (n =2 7 4 , 6 0 1 ) .T h ea v e r a g e
number of citations per item was greatest in 1957, how-
ever, when 40 items were responsible for 2,767 citations,
returning an average of 69.01 citations per item pub-
lished. There has been a downward trend in the average
number of citations per item since the millennium.
Country of origin
A total of 155 different countries contributed to the litera-
ture on breast cancer over the study period. The United
States was responsible for the greatest output, returning
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Page 2 of 977,101 items. Other high output countries included the
United Kingdom (n =1 8 , 3 5 7 ) ,G e r m a n y( n =1 2 , 5 2 9 ) ,I t a l y
(n = 10,828) and Japan (10,109) (Table 1). Density equalis-
ing mapping of this dataset demonstrates that a relatively
small number of countries was responsible for the major-
ity of the output (Figure 2). The Gambia had the highest
average citation rate per item (67.67), followed by Kenya
(40.69), and Costa Rica (39.53) (Table 1). When confined
to those countries which had produced at least 30 items,
however, those with the highest average citation per item
were Iceland (56.62), Finland (35.48), Denmark (32.88)
and Switzerland (31.85) (Figure 3).
Cooperation analysis was employed to assess bilateral
and multilateral cooperation from 1973 to 2008; the first
item in the dataset produced as a result of international
cooperation was published in 1973. In total, 142 different
countries had collaborated on at least one item published.
International cooperation increased steadily through the
study period, reaching a peak in 2008, with 3,127 entries
produced as a result of cooperation. Bilateral cooperation
was the most common form of cooperation (19,437
entries), followed by trilateral cooperation (n = 3,157) and
quadrilateral cooperation (n = 836). Cooperation between
the United States and Canada was the most common form
of bilateral cooperation (n = 2,223), followed by that
between the United States and the United Kingdom (n =
2,007) (Figure 4). Relationships between the United States
and other countries formed the basis for the 10 most com-
mon forms of bilateral cooperation (Table 2).
Publishing journals
A total of 4,096 journals had published at least one item
on breast cancer. The journals which have published
most prolifically on breast cancer, led by Cancer
Research (5,290 items), are listed in Table 3. The top 50
most prolific titles, representing just 1.2% of all contri-
buting journals, together accounted for over 43%
(77517/180126) of the total output. Thirty of these top
50 titles were in the category ‘Oncology’ of the Journal
Citation Report; other represented subject categories
included ‘Surgery’ (n =5 ) ,‘Pathology’ (n =4 ) ,‘Radiol-
ogy, Nuclear Medicine and Medical Imaging’ (n =4 ) .
‘Biochemistry and Molecular Biology’ (n = 3), and ‘Med-
icine, General and Internal’ (n = 3). The median impact
factor (IF) and Eigenfactor (EF) of these titles was 4.73
and 0.05, respectively. Cancer Research also recorded
the highest number of citations overall (n = 309,568),
followed by the Journal of Clinical Oncology (n =
177,189), Cancer (n = 166,834), the Journal of the
National Cancer Institute (JNCI) (n = 131,637), and the
British Journal of Cancer (n = 110,307) (Table 3).
Discussion
In his seminal work on the exponential growth of
science, Little Science, Big Science, Price noted in 1963
that all of the scientific periodicals founded since the
first, the Journal de Scavaus (first published in 1665), had
together produced a world total of six million scientific
papers over the course of the preceding 300 years [17].
Figure 1 Total breast cancer-related output and associated citations, Web of Science, Science Citation Expanded Database, 1945-2008.
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from 1978 to 2001, a total of 8.1 million articles were
published in Medline [18]. The results of this present
analysis have demonstrated this growth in breast cancer
research specifically, with an average 15% increase in out-
put annually since 1945, and a greater than 100% increase
since the millennium alone. This compares with a recent
analysis of total scientific output from PubMed, which
estimated an average growth rate of 4% per year between
1957 and 2007 [4].
This analysis has employed the citation count as a
proxy measure of research quality. Forming an essential
component in the dialogue of medical research [19], cita-
tions are regarded as a key indicator of the relevance and
importance of a published item. We have shown a paral-
lel increase in citation count with the number of breast
cancer-related articles, a not unexpected finding recently
mirrored in analyses of scientific output on scoliosis [20]
and asthma [10]. The average number of citations per
year was highest in 1957, although this was thanks largely
to the citation classic by Bloom and Richardson in which
they outlined their system for the histological grading of
breast cancer and its association with prognosis [21]; it
has since been cited 2,259 times. To put this figure into
perspective, Garfield noted in 2006 that of 38 million
items cited from 1900 to 2005, only 0.5% were cited
more than 200 times [15]. Although there has been a
decreasing trend in the average number of citations per
item since the mid-1990 s, it is difficult to draw firm con-
clusions on the relevance of this finding; it may be
explained by the sharp increase in the number of outputs
in the intervening years, or indeed by the time-lag asso-
ciated with citation analysis which results in an inherent
bias towards older publications.
This analysis has demonstrated the leading role which
the United States plays in breast cancer research, a find-
ing previously noted in other scientific disciplines
[22,23]. This is not surprising given the enormous
Table 1 Leading countries by output and average citations per item, 1945-2008
Top countries - output Top countries - average citings per item
Rank Country No. Publications Times Cited Country No. Publications Times Cited Average Citings/Item
1 United States 77,101 2,389,337 Gambia 3 203 67.67
2 UK 18,357 484,550 Kenya 16 651 40.69
3 Germany 12,529 256,883 Costa Rica 19 751 39.53
4 Italy 10,828 227,078 Finland 2,334 82,802 35.48
5 Japan 10,109 205605 Denmark 2,377 78,163 32.88
6 France 9,412 235,248 Switzerland 2,989 95,201 31.85
7 Canada 9,002 266,803 Netherlands 5,594 173,652 31.04
8 Netherlands 5,594 173,652 United States 77,101 2,389,337 30.99
9 Australia 4,531 110,100 Sweden 4,102 125,209 30.52
10 Sweden 4,102 125,209 Canada 9,002 266,803 29.64
11 Spain 3,680 73,845 Norway 1,884 55,816 29.63
12 China 3,593 42,761 Haiti 1 29 29.00
13 Switzerland 2,989 95,201 Philippines 28 772 27.57
14 Belgium 2,636 66,095 Uganda 9 247 27.44
15 Denmark 2,377 78,163 UK 18,357 484,550 26.40
16 Finland 2,334 82,802 South Africa 475 12208 25.70
17 Austria 2,136 38,079 New Zealand 662 16,820 25.41
18 South Korea 2,118 25,614 Israel 2,086 52,416 25.13
19 Israel 2,086 52,416 Belgium 2,636 66,095 25.07
20 Greece 1,947 28,110 Rwanda 1 25 25.00
21 Norway 1,884 55,816 France 9,412 235,248 24.99
22 Taiwan 1,645 23,297 Senegal 6 147 24.50
23 India 1,347 11,437 Australia 4,531 110,100 24.30
24 Poland 1,341 21,408 Panama 11 266 24.18
25 Turkey 1,297 8,240 Botswana 1 24 24.00
26 Brazil 969 10,651 Paraguay 1 24 24.00
27 Russia 968 13,507 Mozambique 1 23 23.00
28 Ireland 876 18,979 Tunisia 103 2,321 22.53
29 Singapore 693 13,607 Colombia 27 606 22.44
30 Argentina 597 11,652 Estonia 62 1,356 21.87
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Page 4 of 9Figure 2 Density equalizing calculations, total output by country. Illustration of the total number of breast-related items, per country. The
size of each country has been scaled in proportion to the total number of publications. A colour-coded system shows the publication numbers.
Figure 3 Density equalizing calculations, research quality. Illustration of the average number of citations per breast cancer-related item, per
country. The size of each country has been scaled in proportion to the average number of citations per item. A colour-coded system shows the
average number of citations per item. Threshold excludes countries with <30 items published.
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Page 5 of 9Figure 4 Radar chart of cooperation density. Threshold >25 international cooperative partnerships.
Table 2 Top 25 collaborating relationships, breast cancer-
related items, 1949-2008
Rank Country 1 Country 2 No. Publications
1 Canada United States 2,223
2 United Kingdom United States 2,007
3 Germany United States 1,601
4 Italy United States 1,460
5 Japan United States 1,294
6 France United States 1,129
7 China United States 953
8 Netherlands United States 743
9 Sweden United States 740
10 Australia United States 723
11 Germany United Kingdom 719
12 Switzerland United States 668
13 France United Kingdom 639
Table 2 Top 25 collaborating relationships, breast cancer-
related items, 1949-2008 (Continued)
14 Italy United Kingdom 638
15 Spain United States 559
16 Netherlands United Kingdom 548
17 France Italy 541
18 Israel United States 482
19 Australia United Kingdom 459
20 Germany Netherlands 450
21 France Germany 447
22 Denmark United States 442
23 Germany Switzerland 439
24 Canada United Kingdom 437
25 Finland United States 433
No. Publications, the number of items published as a result of cooperation
between the two countries listed.
Glynn et al. Breast Cancer Research 2010, 12:R108
http://breast-cancer-research.com/content/12/6/R108
Page 6 of 9amount of money spent on the management of breast
cancer there annually; it has been estimated that new
cases of breast cancer diagnosed globally in 2009 alone
will have cost an estimated $28 billion; of this $28 bil-
lion, $16 billion was spent in the United States [24].
In addition to being the single largest contributor to the
literature on breast cancer, the United States has further
played a key role in fostering international cooperation,
in particular with its neighbour Canada, but also with
many European nations, including Germany, the United
Kingdom and Italy.
The large number of nations involved in breast cancer
research reflects its global burden. That said, the map of
global production shown in Figure 2 clearly demonstrates
the dramatic underrepresentation of South America,
Africa, and to a lesser extent, Asia. Given that the major-
ity of the predicted 26% increase in the incidence of
breast cancer by 2020 will occur in the developing world
[24], there needs to be a concerted effort to further
involve these areas in future research initiatives, particu-
larly focusing on how the cost-effective diagnosis and
management of breast cancer can be delivered with levels
of efficacy similar to those presently seen in Europe and
the United States.
The quality of breast-related output from both the
United States and the United Kingdom was high as
measured using the average citation rate per published
item as a proxy measure for quality. In addition, the
Table 3 Leading titles, breast cancer-related items, 1945 to 2008
Top 50 journals by output
Journal IP IF EF Journal IP IF EF
Cancer Res 5290 7.51 0.43 J Pathol 830 5.12 0.04
Cancer 4542 5.24 0.12 Carcinogenesis 821 4.93 0.05
Breast Cancer Res Tr 4210 5.68 0.03 Gynecol Oncol 800 2.92 0.04
Brit J Cancer 4075 4.85 0.09 B Cancer 794 1.09 0.00
J Clin Oncol 4003 17.16 0.35 Biochem Biophys R Co 792 2.65 0.24
Eur J Cancer 3503 4.48 0.05 Breast Cancer Res 780 5.05 0.02
Int J Cancer 3370 4.73 0.11 J Nucl Med 769 6.66 0.05
Clin Cancer Res 2746 6.49 0.22 EJSO 726 2.49 0.01
Anticancer Res 2298 1.39 0.03 Semin Oncol 714 3.96 0.02
JNCI 2286 14.93 0.10 J Surg Oncol 713 2.48 0.01
Oncogene 2125 7.22 0.26 Cancer Chemoth Pharm 650 2.74 0.01
Ann Oncol 2012 4.94 0.05 Geburtsh Frauenheilk 649 0.35 0.00
J Biol Chem 1703 5.52 1.33 Am J Surg 630 2.61 0.03
Lancet 1692 28.41 0.41 Am J Pathol 628 5.70 0.10
Int J Radiat Oncol 1509 4.64 0.07 Endocrinology 619 4.95 0.12
Cancer Epidem Biom 1390 4.77 0.06 Am J Roentgen 614 2.94 0.05
Int J Oncol 1371 2.23 0.03
Am J Epidemiol 1335 5.45 0.08 Top 15 journals - by citation count
Ann Surg Oncol 1261 3.90 0.03 Journal IP Citations AC/I
Cancer Lett 1206 3.50 0.05 Cancer Res 5290 309568 58.52
Eur J Cancer Suppl 1190 3.41 0.00 J Clin Oncol 4003 177189 44.26
Oncol Rep 1148 1.52 0.02 Cancer 4542 166834 36.73
Radiology 1127 6.00 0.09 JNCI 2286 131637 57.58
Breast 1068 2.16 0.01 Brit J Cancer 4075 110307 27.07
N Engl J Med 1048 50.02 0.68 Int J Cancer 3370 96406 28.61
J Steroid Biochem 1031 2.83 0.02 J Biol Chem 1703 93637 54.98
Modern Pathol 1010 4.68 0.03 Oncogene 2125 92621 43.59
Proc Amer Ass Cancer Re 976 - - PNAS 895 91620 102.37
Lab Invest 966 4.58 0.02 NEJM 1048 86248 82.30
Brit Med J 913 12.83 0.16 Clin Canc Res 2746 81183 29.56
JAMA 904 1.77 0.01 Lancet 1692 70743 41.81
Psycho-Oncol 902 3.15 0.01 Breast Cancer Res Tr 4210 57714 13.71
PNAS 895 9.38 1.70 Science 195 57017 292.39
Brit J Surg 883 4.92 0.03 JAMA 904 52380 57.94
IP, items published; IF, impact factor; EF, eigenfactor. IF and EF are taken from Thomson Reuters JCR, 2008.
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Page 7 of 9contribution of many smaller countries, including Ice-
l a n d ,F i n l a n d ,S w i t z e r l a n da n dD e n m a r k ,w a so fh i g h
quality, with all four associated with impressive average
citation rates. Interestingly, all of these countries colla-
borated internationally in a high proportion of their out-
put (Figure 4) (Iceland 110/216, 50.92%; Finland 1,045/
2,334, 44.77%; Switzerland 1,741/2,989, 58.24%; Den-
mark 1,050/2,377, 44.17%), suggesting perhaps that this
form of cooperation results in improved quality, and
hence citation rate, of associated output.
Our finding that the breast cancer-associated research
has been published across over 4,000 journals reiterates
the view that it is now impossible for those working in
breast cancer to ensure that they appraise all of the rele-
vant literature. Our work has, however, identified a core
set of journals publishing on breast cancer, with the top
50 accounting for 43% of the total output. The median
IF and EF of these titles compares particularly well with
the median values for all 143 journals in the JCR cate-
gory oncology in 2008 (2.66, 0.01, respectively), and
alludes to the quality of output in this subject area.
There are a number of limitations to this work. Out-
p u tf r o m1 9 7 4( n = 352, 0.2% of total output) was acci-
dentally excluded during data collection, and hence, was
not included in the subsequent analysis. In addition, this
study has focused on entries contained in the Web of
Science only, and it should be noted that the employ-
ment of other databases including PubMed and Scopus
may have yielded slightly different results. That said,
Web of Science covers the oldest publications with
archived records back to 1900 [25], and should provide
an accurate overview of output over the entire study
period. Finally, while we have provided an overview of
geographic output on breast cancer, we have not related
our findings to underlying socio-economic and demo-
graphic variables, and clearly this would be an interest-
ing future avenue for investigation.
Conclusions
This work represents the first bibliometric assessment of
research quantity and quality in breast cancer-associated
literature. The results have demonstrated the ongoing
expansion of that literature, while also identifying the
key nations and journals involved in its production over
the past half-century. In an era when bibliometric indi-
cators are increasingly being employed in the assessment
of individual, institutional and national performance,
these findings should provide useful information for
those tasked with improving that performance.
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